First Do No Harm: Independent Medicines and Medical Devices Safety Review publishes its recommendations
The Independent Medicines and Medical Devices Safety Review, chaired by Baroness Julia Cumberlege, has today published its report. Titled 'First Do No Harm', it comes...
People with neurological conditions lose out due to COVID-19 delays
In a recent survey of more than 1600 people with neurological conditions, over 7 in 10 respondents said they had experienced delays to their...
Without support for services post COVID-19 mental health crisis awaits
The BMA is warning that we could face a post COVID-19 mental health crisis if urgent support not provided for services. The BMA says...
People with diabetes ‘forgotten’ amid imminent easing of lockdown
People with diabetes have been ‘forgotten’ amid imminent easing of lockdown according to Diabetes UK. They say that steps to ease lockdown and reopen...
New online tool pinpoints HIV health inequalities in England
A new online tool has been launched which pinpoints HIV health inequalities in England, it's hoped it will improve prevention and planning. The rate of...
COVID-19 forces radical changes in NHS finance
Oli Hudson, Content Director at Wilmington Healthcare, discusses how COVID-19 is forcing radical changes in NHS finance and gives an overview of the latest...
STADA Health Report 2020: The future of health in Europe
The second international STADA Health Report on the future of health in Europe shows how people in Europe handle future-oriented health topics. A topic which...
Impact of COVID-19 on private healthcare
New data shows the impact of COVID-19 on private healthcare in the UK. The pandemic has led to an estimated 84% drop in privately...
New osteoporosis partnership for post-fracture care
UCB and Amgen have announced a collaboration with the International Osteoporosis Foundation (IOF) to combat the global public health burden of osteoporosis and proactively...
New cancer blood test up to 10 times more sensitive
A new cancer blood test to analyse patients’ blood for evidence of the disease could be up to ten times more sensitive than previous...
Latest articles
Merck discontinues development of its COVID-19 vaccines
Merck, known as MSD outside the United States and Canada, has announced that the company is discontinuing development of its two COVID-19 vaccine candidates,...
COVID-19 vaccination programme ramps up with 30 new centres
More than 30 new NHS Vaccine Centres will start delivering COVID-19 jabs this week as the health service continues to accelerate the biggest immunisation...
Isle of Man set to become world-leading exporter of medicinal cannabis
The Isle of Man Government has passed new regulations to create a comprehensive framework to issue licenses for the production, distribution and export of...
Popular articles
Study shows anti-parasitic drug ivermectin kills coronavirus within 48 hours
A collaborative study led by the Monash Biomedicine Discovery Institute (BDI) with the Peter Doherty Institute of Infection and Immunity (Doherty Institute), a joint...
New Normal, New Thinking: Life Post COVID-19
New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
Nasal spray to protect against COVID-19 is ready for use in humans
A nasal spray to provide protection against the COVID-19 virus has been formulated by researchers at the University of Birmingham, UK, using compounds already...
JCVI updates priority list for COVID-19 vaccine
The Joint Committee on Vaccination and Immunisation (JCVI) has advised that the first priorities for any COVID-19 vaccination programme should be the prevention of...
Isle of Man set to become world-leading exporter of medicinal cannabis
The Isle of Man Government has passed new regulations to create a comprehensive framework to issue licenses for the production, distribution and export of...